Article
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance
11 Feb 2023
Abstract excerpt
Advanced cutaneous melanoma is the deadliest form of skin cancer and one of the most aggressive human cancers. Targeted therapies (TT) against BRAF mutated melanoma and immune checkpoints blockade therapies (ICB) have been a breakthrough in the treatment of metastatic melanoma. However, therapy-driven resistance remains a major hurdle in the clinical management of the metastatic disease. Besides shaping the tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
